Astex Announces Clinical Trial Authorization for Novel Cancer Drug AT7519 and Plans for Two Further New Drug Filings in the Next Nine Months

| Source: Astex Therapeutics Astex Therapeutics

CAMBRIDGE, U.K., May 23, 2005 (PRIMEZONE) -- Astex: 


 -- Astex announces first CTA for novel cancer drug

 -- AT7519 went from first synthesis to CTA approval in just 14 months 
    -- less than half the industry average

 -- Signifies transition from platform to product company

Full press release attached below: http://hugin.info/132636/R/995337/150883.pdf 


            








        

            

                

                    
Mot-clé

                            
                                INTERNATIONAL
                            
                            
                                HEALTH
                            
                            
                                MEDICAL
                            

                



        




    

        

        
Coordonnées